SCHEMBL7175491

SCHEMBL7175491

CC(=O)OC1CCCc2ccc(OCc3ccncc3)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.44
RXRB P28702 3/20 0.44
RXRG P48443 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CHRM4 P08173 2/20 0.42
DRD2 P14416 2/20 0.42
HTR7 P34969 2/20 0.42
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR1 P03372 1/20 0.40
NR3C1 P04150 1/20 0.40
ESR2 Q92731 1/20 0.40
HRH3 Q9Y5N1 2/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7175494 1.00 RXRA (0.44) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7623162 0.84 RXRA (0.39) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7176955 0.82 CSF1R (0.42) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7177129 0.82 CSF1R (0.42) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7175987 0.82 CSF1R (0.42) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7182343 0.80 ACHE (0.48) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7625150 0.77 HRH3 (0.36) RXRARXRBRXRGNPC1RAB9A
SCHEMBL7184465 0.74 FKBP1A (0.54)
SCHEMBL9097746 0.73 FAAH (0.41) NPC1RAB9AMAOAMAOBFFAR1
SCHEMBL8462058 0.73 RXRB (0.61) RXRARXRBRXRGNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941112-B1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS VERTEX PHARMA (US) 2003-02-12 EP disclosed
EP-0839143-B1 TETRALIN COMPOUNDS WITH MDR ACTIVITY VERTEX PHARMA (US) 2002-08-07 EP disclosed
US-5811434-A ADMINISTERING A COMPOSITION COMPRISING A NEUROTROPHIC AMOUNT OF A COMPOUND AND A NEUROTROPHIC FACTOR, SUCH AS NERVE GROWTH FACTOR VERTEX PHARMACUETICALS INCORPORATED (US) 1998-09-22 US disclosed